Skip to content


Matthew Segall

Chief Executive Officer - Optibrium

Emily Fang

Deputy Director of Business Development - Oncodesign Service Business Unit

Yann Gaston Mathé

Chief Executive Officer & Co-founder - Iktos

Connor Coley

Henri Slezynger Career Development, Assistant Professor - MIT

Jean-Philip Piquemal

CSO at Qubit Pharmaceuticals and Professor at Sorbonne Université

Ola Engkvist

Senior Director, Head Molecular AI - AstraZeneca

Didier Rognan

Director of the Laboratory for Therapeutic Innovation - University of Strasbourg

Anouk Huyghebaert

Intern at UCB

Hideyoshi Fuji

Chief Executive Officer & Founder - Chemoinfo

Woody Sherman

Chief Computational Scientist, Roivant Sciences & CEO, D2B Vant

Jonathon Gast

Senior Application Scientist - Nanome

Alex Clark

Research Scientist - Collaborative Drug Discovery - CDD VAULT

Lieven Gevers

Workflow Architect - Chemspeed

Quentin Perron

Chief Scientific Officer & Co-founder - Iktos

Alessandro Monge

Senior Vice President, Head of US Operations and Business Development - Iktos

Pieter Stouten

Director Computational Technologies - Galapagos

Abhinav Kumar

Head of Strategy and Business Development, Reaxys Chemistry Solutions - Elsevier

Maxime Langevin

CIFRE Associate Scientist, Sanofi & Ph.D. candidate, Ecole Normale Supérieure

Brian Atwood

Applications Scientist - Iktos [email protected]

John Wai

Vice President - WuXi AppTec

Eric Jamois

Director, Key Accounts & Strategic Alliances - Simulations Plus

Sree Vadlamudi

Vice President, Head of Business Development EU, RoW

Philippe Gendreau

Data scientist - Iktos

Massina Abderrahmane

Data Scientist - Iktos

Markus Fischer

Product Manager, Technical Integration - Elsevier

Hosted by


Incorporated in October 2016, Iktos is a company specialized in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing an innovative solution based on deep learning generative models, which enables, using existing data, to design molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. Iktos offers its technology both as professional services and as a SaaS software platform, Makya™. Iktos is also developing Spaya™, a synthesis planning software based upon Iktos’s AI technology for retrosynthesis.

Share on


Simulations Plus

ADMET Predictor® is the flagship machine learning platform for ADMET modeling with extended capabilities for data analysis, metabolism prediction, and AI-driven drug design.


Elegant software that guides successful drug discovery

Collaborative Drug Discovery

Single source of truth for your chemical and biological data


Oncodesign is an innovation-based solutions and expertise provider in Drug Discovery in Oncology, Immuno-oncology, and Inflammatory Diseases.


The Ultimate Interface for Drug Discovery


Elsevier is a leader in information and analytics for customers across the global research and health ecosystems.


Artificial Intelligence for new drug design

Chemspeed Technologies

Chemspeed Technologies focuses on creating, developing and delivering full workflow application oriented solutions which enhance R&D productivity.